Back

10 years after treatment with renal denervation of the sympathetic nerves for resistant hypertension: what happened to the patients and their office blood pressure? An observational study

1 September 2024 (14:00 - 14:50)
Organised by: Logo
Congress Presentation Part of: Secondary and resistant hypertension Device Treatment and Intervention ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Thomas Melchior

Roskilde University Hospital, Roskilde (Denmark)

8 More presentations in this session

Presentation thumbnail
Prediction of outcome in malignant hypertension patients using machine learning: a report from the West Birmingham malignant hypertension registry
Doctor A. Argyris (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Ten-year outcomes in patients with hypertension and primary hyperaldosteronism undergoing surgical adrenalectomy versus medical therapy: data from the multinational collaborative network TriNetX
Doctor R. Belo Nunes (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
The effect of spironolactone versus eplerenone on blood pressure targets in resistant hypertension patients.
Mrs L. Mishchenko (Kyiv, UA)
Abstract Slides Video
Presentation thumbnail
Cerebral damage after malignant hypertensive crisis: cerebral MRI follow-up data
Doctor J. Liegey (Bordeaux, FR)
Abstract Slides Video
Presentation thumbnail
Impaired systemic microvascular function in patients with resistant arterial hypertension and microalbuminuria: an observational study
Doctor E. Tibirica (Rio de Janeiro, BR)
Abstract Slides Video

Access the full session

Session thumbnail
Secondary and resistant hypertension

The Event

Event poster

ESC Congress 2024

1 September 2024 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Early and sustained blood pressure control from discharge to 12 months after renal denervation: a time in therapeutic range analysis from a nationwide resistant hypertension registry
thumbnail
Congress Presentation
Renal denervation in hypertensive patients with renal impairment: ultra-long-term follow-up study
thumbnail
Congress Presentation
Renal denervation is one of the pillars of management of resistant hypertension: pro

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources